Biomarkers of blood–brain barrier and neurovascular unit integrity in human cognitive impairment and dementia
Биомаркеры целостности гематоэнцефалического барьера и нейроваскулярной единицы при когнитивных нарушениях и деменции у человека
2025-03-01
SCID: 54.1/kaf34upm
Discuss with AI
Alzheimer's disease and related dementiasblood-brain barrier dysfunctioncerebrospinal fluid biomarkersfluid biomarkersneurovascular unit integrity
Figures from the paper
Abstract (AI)
Blood-brain barrier (BBB) dysfunction is recognized as an early step in the development of Alzheimer's disease and related dementias (ADRD). Biomarkers are needed to monitor BBB integrity over time, better understand the role of the BBB in neurodegeneration, potentially help define long-term ADRD risk, and monitor effects of therapeutics. In this review, we discuss the current biomarkers used to detect human BBB dysfunction in the context of cognitive decline and dementia. We also discuss promising candidate fluid biomarkers to detect BBB dysfunction in blood. HIGHLIGHTS: BBB permeability occurs during normal aging and is further exacerbated in ADRD. In this review, we discuss in vivo imaging and CSF biomarkers of BBB dysfunction currently used in the setting of aging and ADRD in humans. We also review promising candidate blood-based biomarkers that may represent BBB dysfunction.
Key Findings
1
BBB biomarkers could support understanding neurodegeneration, estimating long-term dementia risk, and monitoring therapeutic effects.
2
BBB permeability occurs during normal aging and is further exacerbated in Alzheimer’s disease and related dementias.
3
Blood–brain barrier dysfunction is recognized as an early event in the development of Alzheimer’s disease and related dementias.
4
Human in vivo imaging and cerebrospinal fluid biomarkers are currently used to assess BBB dysfunction in aging and dementia.
5
Promising blood-based fluid biomarkers may enable less invasive detection and longitudinal monitoring of BBB dysfunction.
Research Object
The human blood–brain barrier and neurovascular unit in the context of cognitive impairment, normal aging, and Alzheimer’s disease and related dementias
Research Subject
Biomarkers and biomarker-based assessment of blood–brain barrier and neurovascular unit integrity and dysfunction, including imaging, CSF, and blood-based measures
Publication Details
Publication Date
2025-03-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest